CVX
25
14
DGX
28
4
L
54
5
VMC
41
2
PH
60
5
EQT
47
13
AAL
56
5
HES
49
2
IPG
43
3
GM
55
6
BXP
39
5
MHK
25
5
STT
48
4
KIM
58
2
MCO
67
3
PNC
48
6
HBAN
47
7
VIX
41
-11
KO
44
2
D
32
10
CVX
25
14
DGX
28
4
L
54
5
VMC
41
2
PH
60
5
EQT
47
13
AAL
56
5
HES
49
2
IPG
43
3
GM
55
6
BXP
39
5
MHK
25
5
STT
48
4
KIM
58
2
MCO
67
3
PNC
48
6
HBAN
47
7
VIX
41
-11
KO
44
2
D
32
10
Financhill
Back

Liberty Latin America Vs. Novo Nordisk AS Industry Stock Comparison

Sell
20

LILAK
Liberty Latin America

Last Price:
$6.24
Seasonality Move:
-0.79%
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%
Sell
20
Liberty Latin America (LILAK) is a Sell

Is Liberty Latin America a Buy, Sell or Hold?

  • The current Liberty Latin America [LILAK] share price is $6.23. The Score for LILAK is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • LILAK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
13
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

LILAK Stock Price Chart

What is Liberty Latin America's stock price today?

  • The Liberty Latin America share price today is $6.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LILAK is experiencing slight selling pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $84.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

LILAK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 27.68 Sell
Chaikin Money Flow: -448795 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.51 - 7.05) Sell
Bollinger Bands (100): (7.44 - 10.04) Sell

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.51 Sell
Relative Strength Index (14 RSI): 24.55 Sell
Chaikin Money Flow: 64911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.57 - 111.43) Sell
Bollinger Bands (100): (107.18 - 131.16) Sell

LILAK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.54 Sell
20-day SMA: 6.78 Sell
50-day SMA: 7.95 Sell
200-day SMA: 8.53 Sell
8-day EMA: 6.48 Sell
20-day EMA: 6.8 Sell
50-day EMA: 7.6 Sell
200-day EMA: 8.35 Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 106.85 Sell
50-day SMA: 109.33 Sell
200-day SMA: 126.14 Sell
8-day EMA: 102.09 Sell
20-day EMA: 105.65 Sell
50-day EMA: 110.06 Sell
200-day EMA: 118.01 Sell

Liberty Latin America Earnings Growth & LILAK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.67 per share, and an increase next year of $2.24 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Liberty Latin America Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):